BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
Clinical trial NCT05780424 · COMPLETED
Trial details
- NCT number
- NCT05780424
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-16
- Primary completion
- 2021-06-08
- Enrollment
- 353
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.